COMT inhibition in the treatment of Parkinson's disease: Neuroprotection and future perspectives

被引：0
|
作者：
Kostic, VS [1 ]
机构：
[1] Inst Neurol CCS, YU-11000 Belgrade, Serbia
来源：
FRONTIERS IN CLINICAL NEUROSCIENCE: NEURODEGENERATION AND NEUROPROTECTION: A SYMPOSIUM IN ABEL LAJTHA'S HONOUR | 2004年 / 541卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：75 / 90
页数：16
相关论文
共 50 条
  • [21] Neuroprotection in Parkinson's disease
    Montastruc, JL
    Rascol, O
    Senard, JM
    LANCET, 1996, 347 (8995): : 196 - 196
  • [22] Neuroprotection for Parkinson's disease
    LeWitt, P. A.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2006, (71): : 113 - 122
  • [23] Neuroprotection in Parkinson's disease
    Korlipara, LVP
    Schapira, AHV
    MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE, 2002, 51 : 373 - 378
  • [24] Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives
    Yadav, Virendra Kumar
    Dhanasekaran, Seshathiri
    Choudhary, Nisha
    Nathiya, Deepak
    Thakur, Vishal
    Gupta, Rachna
    Pramanik, Sheersha
    Kumar, Pankaj
    Gupta, Nishant
    Patel, Ashish
    FRONTIERS IN MEDICINE, 2025, 12
  • [25] COMT inhibitors in Parkinson's disease
    Rivest, J
    Barclay, CL
    Suchowersky, O
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 : S34 - S38
  • [26] Opicapone (Ongentys): A New COMT Inhibitor for the Treatment of Parkinson's Disease
    St Onge, Erin
    Vanderhoof, Michelle
    Miller, Shannon
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (09) : 1159 - 1166
  • [27] The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease
    Schapira, AHV
    Obeso, JA
    Olanow, CW
    NEUROLOGY, 2000, 55 (11) : S65 - S68
  • [28] Treatment approaches of gastrointestinal dysfunction in Parkinson's disease, therapeutical options and future perspectives
    Woitalla, D.
    Goetze, O.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 310 (1-2) : 152 - 158
  • [29] COMT Inhibitors in the Management of Parkinson's Disease
    Fabbri, Margherita
    Ferreira, Joaquim J.
    Rascol, Olivier
    CNS DRUGS, 2022, 36 (03) : 261 - 282
  • [30] The effect of COMT inhibition with entacapone on cardiorespiratory responses to exercise in patients with Parkinson's disease
    Lyytinen, J
    Kaakkola, S
    Gordin, A
    Kultalahti, ER
    Teräväinen, H
    Sovijärvi, A
    PARKINSONISM & RELATED DISORDERS, 2002, 8 (05) : 349 - 355
12345